Search:
 

Donor contributions and commitments

National governments and institutions support GAVI in three different ways by:

  • direct donations to GAVI
  • making long-term pledges to The International Finance Facility for Immunisation (IFFIm) which in turn gives GAVI large one-off grants
  • making pledges to The Advance Market Commitment (AMC) which is supporting the development and availability of a pneumococcal vaccine for developing countries.

Learn more about each donor’s support below.

AUSTRALIA
Direct - US $ 20.00 million over 4 years
In 2006 Australia made its first contribution of US$ 5.00 million to the GAVI Alliance, pledging to provide annual grants of US$ 5.00 million to the end of 2009.
 
CANADA
Direct - US $ 158.93 million over 7 years
Canada made its first contribution to the Alliance in 2002, with a donation of US$ 1.88 million, and by the end of 2006 had contributed US$ 148.73 million. Additional pledges bring its total commitment to US$ 158.93 million to the end of 2008.
AMC - US$ 200.00 million
In February 2007 Canada committed US$ 200.00 million to launch the first Advance Market Commitment (AMC) to help speed the development and availability of pneumococcal vaccines.
 
DENMARK
Direct - US $ 37 million over 12 years
One of GAVI’s original six donors, with a contribution of US$ 9.3 million between 2001 and 2006, Denmark made an additional commitment in 2007 of US$ 4.7 million per year to the end of 2012.
 
EUROPEAN COMMISSION
Direct - € 43.00 million (US $ 58.00 million)** over 5 years
Since 2003 the European Commission has committed a total of up to € 43.00 million (US $ 58.00 million)** spanning a period of five years. € 23.00 million of this has come from the Development Co-operation Instrument (DCI), and
€ 20.00 million has come from the intra-ACP envelope in the ninth European Development Fund for the benefit of ACP countries.
 
FRANCE
Direct - € 15 million (US $ 18.66 million to GAVI) ** over 3 years
France made a three year commitment to GAVI in 2003 of
€ 5 million per year for the next three years, bringing France's total to US$ 18.66 million by 2006.
IFFIm - € 1.24 billion to IFFIm over 20 years
In 2006, France made an initial commitment to IFFIm of € 372.80 million over 20 years in 2006. An additional pledge in 2007 for 19 years brings France’s total commitment to IFFIm to € 1,240 billion.
 
GERMANY
Direct - € 8.00 million (US $ 10.54 million)** over 2 years
Germany made a first contribution to GAVI of € 4.00 million (US $ 5.27 million)** at the end of 2006 and another € 4.00 million in 2007. Germany is preparing for this pledge to be renewed at the same levels until the end of 2012.
 
IRELAND
Direct - US $ 26.32 million over 7 years
Ireland made its first contribution in 2002 of US$ 0.51 million. Additional contributions and commitments will bring the total to US$ 26.32 million to the end of 2008.
 
ITALY
IFFIm - € 473.45 million to IFFIm over 20 years
In 2005 the Italian Government committed € 473.45 million to IFFIm over 20 years.
AMC - US$ 635.00 million
In February 2007 Italy committed US$ 635.00 million to launch the first Advance Market Commitment (AMC) to help speed the development and availability of pneumococcal vaccines.
 
LUXEMBOURG
Direct - US $4.1 million over 5 years
Luxembourg made its first contribution in 2004 of US $ 0.65 million. In 2008 Luxembourg is increasing its anual support to US $1.3 million bringing total contributions over five years to US $ 4.1 million.
 
THE NETHERLANDS
Direct - US $ 229 million over 10 years
One of GAVI’s original six donors, the Dutch Government began contributing to the GAVI Alliance in 2001 with annual payments of around US $ 17.00 million. In 2007 it increased its suport to GAVI with a new four-year commitment of US $ 36.00 million annually.
 
NORWAY
Direct - US $ 1.00 billion to GAVI over 15 years
One of GAVI’s original six donors, Norway initially gave US$ 17.89 million in 2001 with a total contribution of US$ 291.89 million up to 2007. In addition, Norway made a pledge in 2005 to provide US$ 750 million over 10 years which would bring the total support from Norway to US$ 1.00 billion to the end of 2015.
IFFIm - US $ 27.00 million to IFFIm over 5 years
Norway committed US$ 27.00 million to IFFIm over five years.
AMC - US$ 50.00 million
In February 2007 Norway committed US$ 50.00 million to launch the first Advance Market Commitment (AMC) to help speed the development and availability of pneumococcal vaccines.
 
RUSSIAN FEDERATION
AMC - US$ 80.00 million
In February 2007 Russia committed US$ 80.00 million to launch the first Advance Market Commitment (AMC) to help speed the development and availability of pneumococcal vaccines which are expected to save the lives of more than 7 million children by 2030.
 
SOUTH AFRICA
IFFIm - US $ 20.00 million to IFFIm over 20 years
South Africa is the most recent country to join the IFFIm donor group committing US$ 20.00 million over 20 years.
 
SPAIN
IFFIm - € 189.50 million to IFFIm over 20 years
Spain became a donor to IFFIm in 2006 with a commitmentof € 189. 50 million over 20 years.
 
SWEDEN
Direct - US $ 66.77 million to GAVI over 8 years
One of the Alliance’s original six donors,Sweden initially contributed US$ 1.89 million in 2001 and substantially increased funding to a total of US$ 66.77 million to the end of 2008.
IFFIm - SEK 276.15 million to IFFIm over 15 years
Sweden also committed funds to IFFIm with a total of SEK 276.15 million to be paid over 15 years.
 
UNITED KINGDOM
Direct - US $ 115.59 million over 9 years
One of GAVI’s original six donors, with a contribution of US$ 4.46 million in 1999, the United Kingdom has committed US$ 115.59 million to 2008.
IFFIm - £ 1.38 billion to IFFIm over 20 years
The UK has committed a total of £ 1.38 billion to IFFIm over 20 years.
AMC - US$ 485.00 million
In February 2007 the United Kingdom committed US$ 485.00 million to launch the first Advance Market Commitment (AMC) to help speed the development and availability of pneumococcal vaccines.
 
UNITED STATES
Direct - US $ 421.81 million over 7 years
One of GAVI’s original six donors, with a contribution of US $ 48.09 million in 2001, the US has increased its annual contributions resulting in a total ofUS$ 421.81 million over seven years.
 
THE WORLD BANK
Direct - US $ 1.50 million over 2 years
The World Bank, a member of the GAVI Alliance, contributed US$ 1.00 million in 2006 and US$ 0.50 million in 2007.

Private Donors

THE BILL & MELINDA GATES FOUNDATION
Direct - US $ 1.51 billion over 15 years
The Bill & Melinda Gates Foundation is a founding partner of the GAVI Alliance. Its initial five-year grant in 1999 helped establish the GAVI Fund. The Foundation pledged a further US$ 750 million in 2005 to support GAVI’s work, committing a total of US$ 1.51 billion to the end of 2014.
AMC - US$ 50.00 million
In February 2007 the Bill & Melinda Gates Foundation committed US$ 50.00 million to launch the first Advance Market Commitment (AMC) to help speed the development and availability of pneumococcal vaccines.
 
OTHER PRIVATE DONATIONS
Direct - US $ 8.03 million over 8 years
Philanthropists, foundations and individual donors have contributed US$ 8.03 million to the GAVI Alliance between 1999 and 2007.

All sums are as at February 2008 ** Sums are presented in US dollars using the United Nations Operational Rates of Exchange of May 2006, rounded to two decimal points.